FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells

(2011) Dae Suk Kim et al.   YONSEI MEDICAL JOURNAL

Chemoimmunotherapy

(2010) Leisha A. Emens   CANCER JOURNAL

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

(2010) Redas Trepiakas et al.   CYTOTHERAPY

Improved Endpoints for Cancer Immunotherapy Trials

(2010) A. Hoos et al.   JNCI-Journal of the National Cancer Institute

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Melanoma vaccines: The problems of local immunosuppression

(2009) Marta E. Polak et al.   HUMAN IMMUNOLOGY

Reversible, PET-positive, Generalized Lymphadenopathy and Splenomegaly During High-dose Interferon-α-2b Adjuvant Therapy for Melanoma

(2009) Laura Ridolfi et al.   JOURNAL OF IMMUNOTHERAPY

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Validation of novel imaging methodologies for use as cancer clinical trial end-points

(2008) D.J. Sargent et al.   EUROPEAN JOURNAL OF CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Paradigm Shifts in Cancer Vaccine Therapy

(2008) Jeffrey Schlom et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Suppressive Influences in the Immune Response to Cancer

(2008) Vincenzo Bronte et al.   JOURNAL OF IMMUNOTHERAPY